Trial intelligence / Profile preview

D-Dimer-Guided Extension of Secondary Prophylaxis for VTE

NCT00895505Phase 3Unknown

Sponsor
University Hospital Bonn
Start
Feb 2008
Primary completion
Feb 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of phenprocoumon, warfarin in venous thromboembolism (VTE), sponsored by University Hospital Bonn. Status: unknown.

02

Drugs

phenprocoumonwarfarin
03

Conditions

venous thromboembolism (VTE)

Beyond the preview

Go deeper on NCT00895505.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00895505.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call